We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

197 hedge funds and large institutions have $1.92B invested in Select Medical in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,390% more call options, than puts

Call options by funds: $3.67M | Put options by funds: $246K

2% more capital invested

Capital invested by funds: $1.87B → $1.92B (+$46.6M)

0.18% more ownership

Funds ownership: 142.93%143.12% (+0.18%)

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

1% less funds holding

Funds holding: 198197 (-1)

16% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 75

Holders
197
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
4.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
63
Reduced
75
Closed
24
Calls
$3.67M
Puts
$246K
Net Calls
+$3.42M
Net Calls Change
+$3.55M
Name Holding Trade Value Shares
Change
Change in
Stake
Holocene Advisors
151
Holocene Advisors
New York
$188K +$196K +18,924 New
LPL Financial
152
LPL Financial
California
$187K -$32.1K -3,096 -14%
MYIA
153
Mount Yale Investment Advisors
Colorado
$180K +$10.9K +1,052 +7%
AIP
154
Ameritas Investment Partners
Nebraska
$170K
Ohio Public Employees Retirement System (OPERS)
155
Ohio Public Employees Retirement System (OPERS)
Ohio
$170K
GHCM
156
Glen Harbor Capital Management
California
$161K +$24.9K +2,406 +17%
LWCFA
157
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$147K
LFA
158
Legacy Financial Advisors
Kentucky
$142K +$149K +14,404 New
Zurich Cantonal Bank
159
Zurich Cantonal Bank
Switzerland
$129K
BNP Paribas Financial Markets
160
BNP Paribas Financial Markets
France
$112K -$249K -24,089 -68%
NIT
161
NumerixS Investment Technologies
British Columbia, Canada
$101K +$30.8K +2,970 +40%
PNC Financial Services Group
162
PNC Financial Services Group
Pennsylvania
$92K +$1.46K +141 +2%
Nisa Investment Advisors
163
Nisa Investment Advisors
Missouri
$78K
JA
164
JOYN Advisors
Georgia
$66K -$4.34K -419 -6%
LIA
165
LS Investment Advisors
Michigan
$66K -$2.57K -248 -4%
Acadian Asset Management
166
Acadian Asset Management
Massachusetts
$61K +$57.2K +5,524 +863%
LTFS
167
Ladenburg Thalmann Financial Services
Florida
$55K -$59.6K -5,754 -51%
Walleye Trading
168
Walleye Trading
New York
$50K +$52.4K +5,059 New
AG
169
Advisor Group
Arizona
$49K +$44.9K +4,332 +691%
VCM
170
Versant Capital Management
Arizona
$41K -$52 -5 -0.1%
MOACM
171
Mutual of America Capital Management
New York
$38K +$32.1K +3,100 +424%
Royal Bank of Canada
172
Royal Bank of Canada
Ontario, Canada
$31K -$23.6K -2,280 -43%
Fidelity Investments
173
Fidelity Investments
Massachusetts
$29K +$30.5K +2,949 New
SWA
174
Sutton Wealth Advisors
Florida
$26K
AIM
175
Assured Investment Management
New York
$15K -$70K -6,765 -82%

SEM Hedge Fund Activity: Q3 2018 in Review

197 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2018, worth a combined $1.92B — up 2.5% from $1.87B a quarter earlier.

Fund positioning in SEM was balanced in Q3 2018: 24 funds opened new positions, 24 closed out, 63 added to existing stakes and 75 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $33.1M. The largest seller was OrbiMed, cutting an estimated $77.6M.

  • 197 institutional investors held Select Medical (SEM) as of Q3 2018, down from 198 in Q2 2018.
  • Funds reported $1.92B of Select Medical stock for Q3 2018, up 2.5% quarter-over-quarter.
  • 24 funds opened new Select Medical positions in Q3 2018 and 24 closed out, a net change of 0 holders.
  • The largest Select Medical buyer in Q3 2018 was TimesSquare Capital Management, an estimated $33.1M added.
  • The largest Select Medical seller in Q3 2018 was OrbiMed, an estimated $77.6M sold.

Based on aggregated 13F filings for Q3 2018.